搜索临床试验以:IBI112 第 2 剂
总计21609个结果
-
Merck Sharp & Dohme LLCPfizer完全的
-
Baiya Phytopharm Co., Ltd.National Vaccine Institute, Thailand主动,不招人
-
University Hospital, Clermont-Ferrand完全的
-
Innovent Biologics (Suzhou) Co. Ltd.完全的
-
China National Biotec Group Company LimitedBeijing Institute of Biological Products Co Ltd.主动,不招人
-
Ottawa Heart Institute Research CorporationHeart and Stroke Foundation of Ontario完全的
-
The Cleveland Clinic完全的
-
Boehringer IngelheimEli Lilly and Company完全的
-
Boehringer IngelheimEli Lilly and Company完全的2型糖尿病美国, 澳大利亚, 加拿大, 爱沙尼亚, 法国, 乔治亚州, 德国, 危地马拉, 意大利, 拉脱维亚, 立陶宛, 墨西哥, 新西兰, 波兰, 俄罗斯联邦, 南非, 西班牙, 乌克兰
-
Vanderbilt University Medical CenterAmerican Heart Association主动,不招人
-
Columbia UniversityNational Institute on Drug Abuse (NIDA); Medical University of South Carolina; University of Pittsburgh 和其他合作者完全的
-
Vanderbilt University Medical CenterNational Heart, Lung, and Blood Institute (NHLBI)招聘中
-
Metabolic Technologies Inc.National Institute on Aging (NIA); Vanderbilt University完全的
-
Metabolic Technologies Inc.National Institute on Aging (NIA); Vanderbilt University完全的
-
Children's Hospital Medical Center, CincinnatiNationwide Children's Hospital; University of Cincinnati; Connecticut Children's Medical Center; Broad Institute招聘中
-
Ahmad TarhiniPrometheus Laboratories终止
-
CHU de Quebec-Universite LavalCanadian Institutes of Health Research (CIHR)尚未招聘癌症 | 前列腺癌 | 转移癌 | 转移性前列腺癌
-
Zhongnan Hospital招聘中SARS-CoV-2 | 安全 | 免疫毒性中国
-
Oregon Health and Science UniversityNational Heart, Lung, and Blood Institute (NHLBI); University of Michigan; Children's Hospital... 和其他合作者邀请报名
-
Baylor College of MedicineCenter for Cell and Gene Therapy, Baylor College of Medicine主动,不招人
-
Pearl Therapeutics, Inc.完全的
-
Boryung Pharmaceutical Co., Ltd完全的
-
Sinovac Research and Development Co., Ltd.完全的